Work

A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis (P8-8.011)

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.0000000000204223

Authors: Salman Bhai, Robert Bowser, Suzan Moser, Deborah Taylor, Andrew Heim, Susan Woolley-Levine, Dan Moore, Todd Levine, Richard Barohn

Institutions: The University of Texas Southwestern Medical Center, Barrow Neurological Institute, University of Missouri, University of Kansas Medical Center, Syneos Health (United States), Syneos Health UK Limited (United Kingdom), HonorHealth

Language: English

Topic: Amyotrophic Lateral Sclerosis Research

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367302762

FWCI: 0.512

Cites:

Cited by: 3

Related to: 10